NASDAQ:BCAX | Cash Flow Statement | Bicara Therapeutics Inc.

Complete source-backed cash-flow history.

Available history
2023-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$55.44M
2026-03-31-$56.21M-$37.51M$60,000.00$100.94M$163.35M
2025-12-31-$37.39M-$23.89M$238,000.00-$82.33M$31.23M
2025-09-30-$36.33M
2025-06-30-$27.39M
2025-03-31-$36.85M-$28.11M$0.00$0.00$460,000.00
2024-12-31-$20.96M-$30.03M$40,000.00-$40,000.00-$975,000.00
2024-09-30-$17.48M
2024-06-30-$17.05M
2024-03-31-$12.51M-$14.59M$4,000.00$58,000.00$137,000.00
2023-12-31-$12.44M-$8.04M$436,000.00-$436,000.00$194.7M
2023-09-30-$22.85M
2023-06-30-$9.29M
2023-03-31-$7.41M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$137.95M-$106.83M$280,000.00-$318.45M$32.26M
2024-12-31-$68M-$74.75M$71,000.00-$9,000.00$334.03M
2023-12-31-$51.99M-$45.63M$586,000.00-$586,000.00$272.5M